A single dose of psilocybin produces substantial and enduring decreases in anxiety and depression in patients with a life-threatening cancer diagnosis: A randomized double-blind trial

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2015
This article has no abstract
Epistemonikos ID: 194dc1799820dd14d8b2eb002de20859a305a94c
First added on: Apr 30, 2026